Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Anna Chelchowska

BA, BMBCh (Oxon), PGCert (MedEd)


Clinical Research Fellow in Psychoimmunology

I am a Clinical Research Fellow with the Oxford Autoimmune Psychosis Group. In my role I support the PPIP2 & the SINAPPS2 studies, which aim to investigate the role of anti-neuronal membrane antibodies as a cause of psychosis and whether immunotherapy might be an effective treatment for antibody-associated psychosis. 

In terms of my clinical duties, I hold an honorary contract with the Oxford Health NHS Foundation Trust, where I'm part of the Oxford Early Intervention in Psychosis team, assessing and supporting patients who experience psychosis for the first time. I also co-ordinate the monthly Oxford Antibody MDT, which reviews referrals of complex patients at the intersection of Psychoimmunology and Neuroimmunology.